IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $13,000 | +1200.0% | 1,813 | +602.7% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 258 | +11.2% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 232 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 232 | -16.8% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 279 | -26.2% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 378 | -50.3% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 760 | +34.0% | 0.00% | – |
| Q4 2019 | $3,000 | +200.0% | 567 | +15.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 491 | +105.4% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 239 | -20.6% | 0.00% | – |
| Q1 2019 | $1,000 | – | 301 | +3244.4% | 0.00% | – |
| Q3 2018 | $0 | – | 9 | -35.7% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 14 | -98.6% | 0.00% | – |
| Q4 2016 | $2,000,000 | +66566.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $3,000 | – | 1,000 | – | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2014 | $32,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |